share_log
Reuters ·  Mar 19 12:15
Cero Therapeutics Holdings Inc - on Track for First Patient Dosing in H1 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 330

Recommended

Write a comment